Home>>Lipids>> Glycerophospholipids>>PtdIns-(1,2-dipalmitoyl) (ammonium salt)

PtdIns-(1,2-dipalmitoyl) (ammonium salt) (Synonyms: DPPI, Phosphatidylinositol C-16, PI(16:0/16:0), 16:0/16:0 PI)

Catalog No.GC44741

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids.

Products are for research use only. Not for human use. We do not sell to patients.

PtdIns-(1,2-dipalmitoyl) (ammonium salt) Chemical Structure

Cas No.: 34290-57-8

Size Price Stock Qty
100μg
$87.00
In stock
500μg
$385.00
In stock
1mg
$686.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

The phosphatidylinositol (PtdIns) phosphates represent a small percentage of total membrane phospholipids. However, they play a critical role in the generation and transmission of cellular signals. PtdIns-(1,2-dipalmitoyl) is a synthetic analog of natural phosphatidylinositol (PtdIns) featuring C16:0 fatty acids at the sn-1 and sn-2 positions. The compound features the same inositol and diacylglycerol (DAG) stereochemistry as that of the natural compound. PtdIns are phosphorylated to mono- (PtdIns-P; PIP), di- (PtdIns-P2; PIP2), and triphosphates (PtdIns-P3; PIP3). Hydrolysis of PtdIns-(4,5)-P2 by phosphoinositide (PI)-specific phospholipase C generates inositol triphosphate (IP3) and DAG which are key second messengers in an intricate biochemical signal transduction cascade.

Reviews

Review for PtdIns-(1,2-dipalmitoyl) (ammonium salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PtdIns-(1,2-dipalmitoyl) (ammonium salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.